Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
41.44
-0.17 (-0.41%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
28
29
Next >
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
Via
Benzinga
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
November 10, 2022
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen.
Via
Investor's Business Daily
GSK's Conditionally Approved Blood Cancer Drug Fails On Progression-Free Survival Goal Over Standard Care
November 07, 2022
Via
Benzinga
Week in Review: CBC Plans $137 Million Shanghai Biopharma Complex
November 05, 2022
Deals, financings, trials and approvals in Chinese biotech/biopharma this week.
Via
Talk Markets
Why Vir Biotechnology Jumped Nearly 19% Today
November 04, 2022
A COVID-19 partnership with a major drugmaker is producing more fruit than expected.
Via
The Motley Fool
Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth
November 04, 2022
Sales of Vir Biotechnology and GSK's Covid antibody almost tripled sales estimates.
Via
Investor's Business Daily
Citing Efficacy, GSK Stops Two Pivotal UTI Antibiotic Trials Early
November 03, 2022
Via
Benzinga
GSK Surges As Shingles Vaccine Drives Commanding Third-Quarter Beat
November 02, 2022
Shingrix and specialty medicines helped drive GSK's third-quarter growth.
Via
Investor's Business Daily
GSK Lifts Annual Outlook After Robust Vaccines, Specialty Medicine Sales In Q3
November 02, 2022
Via
Benzinga
Moderna's Earnings Collapsed. Time to Sell?
November 04, 2022
This drugmaker's bottom line fell down a deep hole in the third quarter and investors want to know if it's time to run for the hills.
Via
The Motley Fool
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02
November 02, 2022
Reuters
Via
Benzinga
Recap: GSK Q3 Earnings
November 02, 2022
GSK (NYSE:GSK) reported its Q3 earnings results on Wednesday, November 2, 2022 at 05:00 AM. Here's what investors need to know about the announcement. Earnings GSK beat estimated earnings by 15.63%,...
Via
Benzinga
GSK's Debt Overview
November 01, 2022
Over the past three months, shares of GSK Inc. (NYSE:GSK) decreased by 16.74%. Before having a look at the importance of debt, let's look at how much debt GSK has.
Via
Benzinga
Earnings This Week: AMD, BP And PayPal
October 28, 2022
Find out what to expect from this week's earnings calendar.
Via
Talk Markets
GSK Pulls Plug On Late-Stage Asset Under Development For Rheumatoid Arthritis
October 27, 2022
Via
Benzinga
GSK One Step Closer To FDA Approval For Anemia Drug For Dialysis Patients
October 27, 2022
Via
Benzinga
GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions
October 25, 2022
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
GSK Q3 2022 Earnings Conference Call On November 2, 2022 At 08:00 AM ET
October 28, 2022
GSK (NYSE:GSK) will host a conference call at 08:00 AM ET on November 2, 2022, to discuss Q3 2022 earnings results. How to Attend GSK (GSK) Conference Call Follow this link to access the live webcast.
Via
Benzinga
Is Merck Moving Toward Another Blockbuster Drug Launch?
October 26, 2022
Merck will soon share its positive phase 3 clinical trial results for a rare disease drug candidate at an upcoming event.
Via
The Motley Fool
GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day
October 25, 2022
Via
Benzinga
Children's Hospitals Strained After Climbing Cases In Respiratory Illnesses In Kids
October 21, 2022
Physicians are reporting a sharp increase in cases of the respiratory syncytial virus (RSV), creating capacity issues in several children's hospitals in the U.S. before the typically busier winter...
Via
Benzinga
3 Things the Smartest Investors Know About This Beaten-Down Stock
October 20, 2022
Moderna's story may just be beginning.
Via
The Motley Fool
Peering Into GSK's Recent Short Interest
October 20, 2022
GSK's (NYSE:GSK) short percent of float has risen 12.86% since its last report. The company recently reported that it has 15.83 million shares sold short, which is 0.79% of all regular shares that are...
Via
Benzinga
Boston University's COVID-19 Created In Lab Research Comes Under Scrutiny
October 20, 2022
Boston University created an artificial form of COVID-19 in a laboratory. Now, U.S. health officials have launched an inquiry into a controversial study. The Boston University research was designed to...
Via
Benzinga
7 Quality Stocks Selling at a Discount as Q4 Kicks Off
October 19, 2022
Stocks may have just entered a bull market, so bullish investors should look for quality stocks selling at a discount to buy before a rally.
Via
InvestorPlace
This Addiction Drug Shows Some Potential Against Long COVID Symptoms
October 19, 2022
Researchers are working on cures for long COVID. With some success, naltrexone has been used to treat pain, fatigue, and brain fog months after a coronavirus infection.
Via
Benzinga
Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm'
October 17, 2022
Via
Benzinga
Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13
October 13, 2022
Reuters
Via
Benzinga
GSK Touts 'Exceptional Results' From RSV Vaccine Candidate In Older Adults
October 13, 2022
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.